Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Lactulose vs Lactulose Enema for Hepatic Encephalopathy
NCT05788627Phase 4Unknown
- Sponsor
- Khyber Medical College
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, single-blind trial of lactulose in hepatic encephalopathy (HE), sponsored by Khyber Medical College. Primary endpoint: Change in grade of hepatic encephalopathy at 48 hours. Status: unknown.
02
Drugs
lactulose
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT05788627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05788627.